ATE412738T1 - Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen - Google Patents

Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen

Info

Publication number
ATE412738T1
ATE412738T1 AT00420113T AT00420113T ATE412738T1 AT E412738 T1 ATE412738 T1 AT E412738T1 AT 00420113 T AT00420113 T AT 00420113T AT 00420113 T AT00420113 T AT 00420113T AT E412738 T1 ATE412738 T1 AT E412738T1
Authority
AT
Austria
Prior art keywords
strains
denguevirus
attenuate
vaccine compositions
serotype
Prior art date
Application number
AT00420113T
Other languages
English (en)
Inventor
Nath Bhamarapravat
Sutee Yoksan
Original Assignee
Univ Mahidol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mahidol filed Critical Univ Mahidol
Application granted granted Critical
Publication of ATE412738T1 publication Critical patent/ATE412738T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00420113T 2000-05-30 2000-05-30 Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen ATE412738T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00420113A EP1159968B1 (de) 2000-05-30 2000-05-30 Attenuierte Stammen von Denguevirus und ihre Verwendungen in Impfstoffzusammensetzungen

Publications (1)

Publication Number Publication Date
ATE412738T1 true ATE412738T1 (de) 2008-11-15

Family

ID=8174060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00420113T ATE412738T1 (de) 2000-05-30 2000-05-30 Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen

Country Status (7)

Country Link
EP (1) EP1159968B1 (de)
AT (1) ATE412738T1 (de)
CY (1) CY1108666T1 (de)
DE (1) DE60040652D1 (de)
DK (1) DK1159968T3 (de)
ES (1) ES2315221T3 (de)
PT (1) PT1159968E (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0613287A2 (pt) 2005-06-17 2010-12-28 Sanofi Pasteur cepa do vìrus da dengue-2 vivo atenuada, composição imunogênica, composição de vacina, ácido nucléico isolado, poliproteìna isolada codificadas pela seq id n .1 ou fragmentos desta e fragmento da poliproteìna
JP5197362B2 (ja) * 2005-06-17 2013-05-15 サノフィ・パスツール デング熱セロタイプ１弱毒株
US7968102B2 (en) 2006-01-13 2011-06-28 Sanofi Pasteur S.A. Dengue chimeric viruses
AR061197A1 (es) * 2006-06-07 2008-08-13 Sanofi Pasteur Cepas del virus 3 del dengue vivas atenuadas
FR2903605A1 (fr) 2006-07-12 2008-01-18 Sanofi Pasteur Sa Methode d'immunisation contre les quatres serotypes de la dengue
FR2906724B1 (fr) * 2006-10-04 2009-03-20 Sanofi Pasteur Sa Methode d'immunisation contre les 4 serotypes de la dengue.
FR2909286B1 (fr) * 2006-12-01 2012-06-08 Sanofi Pasteur Methode d'immunisation contre les 4 serotypes de la dengue
KR101695800B1 (ko) 2008-03-05 2017-02-22 사노피 파스퇴르 항원보강제 함유 백신 조성물의 안정화 방법
EP2143440A1 (de) 2008-07-09 2010-01-13 Sanofi Pasteur Stabilisierungssubstanz und Impfzusammensetzung, die ein oder mehrere abgeschwächte lebende Flaviviridae enthält
EP2353609A1 (de) 2010-02-04 2011-08-10 Sanofi Pasteur Immunisierungszusammensetzungen und -verfahren
SG11201500439RA (en) 2012-07-24 2015-02-27 Sanofi Pasteur Vaccine compositions for prevention against dengue virus infection
EP3932422A1 (de) 2012-07-24 2022-01-05 Sanofi Pasteur Impfstoffzusammensetzungen zur vorbeugung von dengue-virus-infektionen
BR112015012515B1 (pt) 2012-11-30 2023-04-11 Sanofi Pasteur Uso de antígenos, construções de ácido nucleico ou vetores virais capazes de expressar uma partícula do tipo vírus (vlp) da dengue e de uma vacina contra sarampo, uma vacina contra caxumba e uma vacina contra rubéola
CA3166063A1 (en) 2013-03-15 2014-09-25 Takeda Vaccines, Inc. Compositions and methods for dengue virus chimeric constructs in vaccines
US10655110B2 (en) * 2015-11-27 2020-05-19 Km Biologics Co., Ltd. Multivalent dengue vaccine composition comprising a mixture of attenuated dengue viruses from different serotypes
WO2017109698A1 (en) 2015-12-22 2017-06-29 Glaxosmithkline Biologicals Sa Immunogenic formulation
SG11202002933TA (en) 2017-10-05 2020-04-29 Sanofi Pasteur Compositions for booster vaccination against dengu
US11426461B2 (en) 2018-09-05 2022-08-30 Takeda Vaccines, Inc. Methods for preventing dengue and hepatitis A

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6093296A (en) * 1995-06-07 1996-12-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Infectious dengue 2 virus pdk-53 as quadravalent vaccine

Also Published As

Publication number Publication date
PT1159968E (pt) 2008-11-20
EP1159968A1 (de) 2001-12-05
CY1108666T1 (el) 2014-04-09
DK1159968T3 (da) 2009-02-23
DE60040652D1 (de) 2008-12-11
EP1159968B1 (de) 2008-10-29
ES2315221T3 (es) 2009-04-01

Similar Documents

Publication Publication Date Title
CY1108666T1 (el) Εξασθενημενα στελεχη του δαγγειου πυρετου και η χρηση τους σε μια συνθεση εμβολιου
BRPI0309631A8 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3 e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
GT200000103A (es) Trifluorbutenos nematocidas.
DE60130987D1 (de) Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
DK1377593T3 (da) 2-Amino-propanolderivater
EP1399163A4 (de) Verbindungen, verfahren und zusammensetzungen für die behandlung von infektionen mit dem rinderdiarrhö-virus (bvdv) und dem hepatitis-c-virus (hcv)
DE69031560D1 (de) Verfahren und zusammensetzungen zum stimulieren von vesikulär-arbuskulären mykorrhizapilzen
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
NO20026044D0 (no) Behandling av human papillomavirus
NO955047L (no) Sekundære aminer som antidiabetiske og antifedme-midler
MA30893B1 (fr) Inhibiteurs de la protease ns3 du vhc
DE60114865D1 (de) Heterologe herstellung von polyketiden
CA2413163A1 (en) 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides
ATE219938T1 (de) Neue 4-arylpiperazine und 4-arylpiperidine
TR199901305T2 (xx) Calpain-�nleyicileri olarak ketonbenzamidler
ECSP045300A (es) Antígenos virales
NO20004978D0 (no) Semi-syntetiske ecteinascidiner
WO2001007027A3 (en) Pyrimidine derivatives for the treatment of viral diseases
DK0409435T3 (da) Heteroarylpiperaziner som antipsykotiske midler
ATE265535T1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
NO924598L (no) Fremstilling av substituerte piperidiner
DK1089625T3 (da) Ektoparasiticide midler
ATE255105T1 (de) Serotonerge benzofurane
DE69928646D1 (de) Derivate des streptogramins, ihre herstellung und sie enthaltende zubereitungen
WO2002072803A3 (en) Subgenomic replicons of the flavivirus dengue

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1159968

Country of ref document: EP